Biodegradable hybrid polymeric membranes for ocular drug delivery.

[1]  K. Pintye-Hódi,et al.  Understanding of the Plasticizing Effects of Glycerol and PEG 400 on Chitosan Films Using Solid-State NMR Spectroscopy , 2009 .

[2]  H. PatelDipti,et al.  Formulation and evaluation of drug-free ophthalmic films prepared by using various synthetic polymers , 2009 .

[3]  Carole Maldonado-Codina,et al.  Corneal staining: do we really understand what we are seeing? , 2009, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[4]  A. Concheiro,et al.  Macromolecule release and smoothness of semi-interpenetrating PVP-pHEMA networks for comfortable soft contact lenses. , 2008, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[5]  Marilyn N. Martinez,et al.  In vitro and in vivo considerations associated with parenteral sustained release products: a review based upon information presented and points expressed at the 2007 Controlled Release Society Annual Meeting. , 2008, Journal of controlled release : official journal of the Controlled Release Society.

[6]  R. Banerjee,et al.  Comparison of ciprofloxacin hydrochloride-loaded protein, lipid, and chitosan nanoparticles for drug delivery. , 2008, Journal of biomedical materials research. Part B, Applied biomaterials.

[7]  J. Klarlund,et al.  Activation of the epidermal growth factor receptor by hydrogels in artificial tears. , 2008, Experimental eye research.

[8]  Hui Xu,et al.  Pluronic F127-g-poly(acrylic acid) copolymers as in situ gelling vehicle for ophthalmic drug delivery system. , 2008, International journal of pharmaceutics.

[9]  J. Kennedy,et al.  Rheological characterisation of a novel thermosensitive chitosan/poly(vinyl alcohol) blend hydrogel , 2007 .

[10]  I. Kołodziejska,et al.  The water vapour permeability, mechanical properties and solubility of fish gelatin–chitosan films modified with transglutaminase or 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide (EDC) and plasticized with glycerol , 2007 .

[11]  Y. Ali,et al.  Industrial perspective in ocular drug delivery. , 2006, Advanced drug delivery reviews.

[12]  Qun Wang,et al.  Alginate/gelatin blend films and their properties for drug controlled release , 2006 .

[13]  G. Nath,et al.  In vitro microbiological evaluation of polyvinyl alcohol-based ocular inserts of Ciprofloxacin hydrochloride , 2006 .

[14]  Kunal Pal,et al.  Polyvinyl Alcohol—Gelatin Patches of Salicylic Acid: Preparation, Characterization and Drug Release Studies , 2006, Journal of biomaterials applications.

[15]  M. Chinnan,et al.  Effect of Plasticizer Type and Concentration on the Properties of Edible Film from Water-Soluble Fish Proteins in Surimi Wash-Water , 2006 .

[16]  T. Hirose,et al.  In vivo and in vitro feasibility studies of intraocular use of seprafilm to close retinal breaks in bovine and rabbit eyes. , 2006, Investigative ophthalmology & visual science.

[17]  Paulo José do Amaral Sobral,et al.  Effects of plasticizers and their concentrations on thermal and functional properties of gelatin-based films , 2005 .

[18]  Asgar Ali,et al.  Ocular inserts for controlled delivery of pefloxacin mesylate: preparation and evaluation. , 2005, Acta pharmaceutica.

[19]  David S. Jones,et al.  Rheological characterisation of primary and binary interactive bioadhesive gels composed of cellulose derivatives designed as ophthalmic viscosurgical devices. , 2005, Biomaterials.

[20]  N. Efron,et al.  Tensile properties of soft contact lens materials. , 2004, Contact lens & anterior eye : the journal of the British Contact Lens Association.

[21]  K. Tsubota,et al.  Ocular surface changes with applanation contact lens and coupling fluid use after argon laser photocoagulation in noninsulin-dependent diabetes mellitus. , 2004, American journal of ophthalmology.

[22]  P. Venables.  Sjögren's syndrome. , 2004, Best practice & research. Clinical rheumatology.

[23]  S. Kawakami,et al.  One-side-coated insert as a unique ophthalmic drug delivery system. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[24]  A. Bernkop‐Schnürch,et al.  Mucoadhesive ocular insert based on thiolated poly(acrylic acid): development and in vivo evaluation in humans. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Y. Gong,et al.  Properties and biocompatibility of chitosan films modified by blending with PEG. , 2002, Biomaterials.

[26]  John Kotelawala,et al.  PREPARATION AND CHARACTERIZATION OF EDIBLE SOYA PROTEIN FILMS , 2002 .

[27]  S. Burgalassi,et al.  Relevance of polymer molecular weight to the in vitro/in vivo performances of ocular inserts based on poly(ethylene oxide). , 2001, International journal of pharmaceutics.

[28]  P Sharma,et al.  In vitro hemolysis of human erythrocytes -- by plant extracts with antiplasmodial activity. , 2001, Journal of ethnopharmacology.

[29]  S. Jayaprakash,et al.  Design and evaluation of polymeric ocular drug delivery system for controlled release of tetracycline HCl , 2001 .

[30]  E. Kurt,et al.  The effects of prolonged acute use and inflammation on the ocular penetration of topical ciprofloxacin. , 2000, International journal of pharmaceutics.

[31]  A. Urtti,et al.  Effect of the CB1 receptor antagonist, SR141716A, on cannabinoid-induced ocular hypotension in normotensive rabbits. , 1998, Life sciences.

[32]  P. Chetoni,et al.  Silicone rubber/hydrogel composite ophthalmic inserts: preparation and preliminary in vitro/in vivo evaluation. , 1998, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[33]  Paul D. Dalton,et al.  THE USE OF HYDROPHILIC POLYMERS AS ARTIFICIAL VITREOUS , 1998 .

[34]  Deshpande,et al.  Ocular drug delivery in veterinary medicine. , 1997, Advanced drug delivery reviews.

[35]  E. Lobel,et al.  A novel in situ-forming ophthalmic drug delivery system from alginates undergoing gelation in the eye , 1997 .

[36]  L. Salminen,et al.  Ocular inserts for topical delivery , 1995 .

[37]  R. Shanker,et al.  An in vitro technique for measuring contact angles on the corneal surface and its application to evaluate corneal wetting properties of water soluble polymers , 1995 .

[38]  R. Gurny,et al.  Long-acting soluble bioadhesive ophthalmic drug insert (BODI) containing gentamicin for veterinary use: optimization and clinical investigation , 1995 .

[39]  M. Torracca,et al.  Controlled release of pilocarpine from coated polymeric ophthalmic inserts prepared by extrusion , 1992 .

[40]  V. Lee,et al.  Improving the safety of topically applied timolol in the pigmented rabbit through manipulation of formulation composition. , 1992, Experimental eye research.

[41]  A. Urtti,et al.  Modification of ocular and systemic absorption of timolol from ocular inserts by a buffering agent and a vasoconstrictor , 1990 .

[42]  A. Urtti,et al.  Improved ocular: systemic absorption ratio of timolol by viscous vehicle and phenylephrine. , 1990, Investigative ophthalmology & visual science.

[43]  D. Scudiero,et al.  New colorimetric cytotoxicity assay for anticancer-drug screening. , 1990, Journal of the National Cancer Institute.

[44]  M. Davies,et al.  2'-Nor-2'-deoxyguanosine is an effective therapeutic agent for treatment of experimental herpes keratitis. , 1987, Antiviral research.

[45]  M. Attia,et al.  Effect of different ointment bases on ocular disposition of ethylphenylephrine in rabbit eyes , 1985 .

[46]  R. Nichols,et al.  In vivo evaluation of ocular inserts of hydrogel impregnated with antibiotics for trachoma therapy. , 1983, Biomaterials.

[47]  A. Bauer,et al.  Antibiotic susceptibility testing by a standardized single disk method. , 1966, American journal of clinical pathology.

[48]  John H. Draize,et al.  METHODS FOR THE STUDY OF IRRITATION AND TOXICITY OF SUBSTANCES APPLIED TOPICALLY TO THE SKIN AND MUCOUS MEMBRANES , 1944 .